Yuki Muranishi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yuki Muranishi has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Masafumi Kon
Department of Renal and Genitourinary Surgery Hokkaido University Graduate School of Medicine Sapporo Japan
3 shared publicationsAtsushi Hattori
Department of Molecular Endocrinology, National Research Institute for Child Health and Development , Tokyo, Japan
2 shared publications- Maki Fukami
Department of Molecular Endocrinology, National Research Institute for Child Health and Development , Tokyo 157-8535
2 shared publications Nobuo Shinohara
Department of Renal and Genitourinary Surgery, Hokkaido University Graduate School of Medicine , Sapporo, Japan
2 shared publicationsToshiyuki Iwahata
International Center for Reproductive Medicine, Dokkyo Medical University Saitama Medical Center , Koshigaya, Japan
2 shared publicationsYoshitomo Kobori
International Center for Reproductive Medicine, Dokkyo Medical University Saitama Medical Center , Koshigaya, Japan
2 shared publications
Latest Publications
- 4 May 2026
- Published by Wiley in International Journal of Urology
- Vol. 33 (5) , e70482
A Novel Prediction Model for Monorchidism in Boys With Unilateral Nonpalpable Testes: Diagnostic Utility of Preoperative Ultrasonography
Introduction: In boys with non‐palpable testis (NPT), the affected side may present as a viable testis (VT) or a nonviable testis (NVT), the latter representing true monorchidism. This study evaluated the utility of ultrasonography (US) for predicting monorchidism and testicular location in unilateral NPT. Methods: We retrospectively reviewed boys with unilateral NPT who underwent preoperative US between 2009 and 2025. Testicular volumes were converted to age‐adjusted standard deviation (SD) scores. A rule‐based model classified NVT when the affected testis was visualized with an SD score ≤ cutoff A and the unaffected testis had an SD score ≥ cutoff B. If the affected testis was not visualized, an SD score ≥ cutoff C for the unaffected testis indicated NVT; remaining cases were classified as VT. Predictions were compared with intraoperative findings. Receiver operating characteristic analysis determined optimal cutoffs. Internal validation using repeated stratified five‐fold cross‐validation and bootstrap resampling assessed model performance and threshold stability. US‐based localization was also compared with surgical findings. Results: Sixty‐nine boys were included; surgery identified 51 NVT and 18 VT. Optimal cutoffs were A = −2.60, B = +0.45, and C = +0.60. The model achieved an AUC of 96.1%, with 100% sensitivity, 92.2% specificity, 81.8% positive predictive value, and 100% negative predictive value. Internal validation showed median AUCs of 90.0% and 89.4%, with stable thresholds. Localization accuracy was 66.6%. Conclusion: A rulebased US model may predict monorchidism in unilateral NPT with a very low risk of misclassifying VT as NVT, despite its limited ability to determine testicular location.
- 4 May 2026
- Published by Wiley in International Journal of Urology
- Vol. 33 (5) , e70482
A Novel Prediction Model for Monorchidism in Boys With Unilateral Nonpalpable Testes: Diagnostic Utility of Preoperative Ultrasonography
Introduction: In boys with non‐palpable testis (NPT), the affected side may present as a viable testis (VT) or a nonviable testis (NVT), the latter representing true monorchidism. This study evaluated the utility of ultrasonography (US) for predicting monorchidism and testicular location in unilateral NPT. Methods: We retrospectively reviewed boys with unilateral NPT who underwent preoperative US between 2009 and 2025. Testicular volumes were converted to age‐adjusted standard deviation (SD) scores. A rule‐based model classified NVT when the affected testis was visualized with an SD score ≤ cutoff A and the unaffected testis had an SD score ≥ cutoff B. If the affected testis was not visualized, an SD score ≥ cutoff C for the unaffected testis indicated NVT; remaining cases were classified as VT. Predictions were compared with intraoperative findings. Receiver operating characteristic analysis determined optimal cutoffs. Internal validation using repeated stratified five‐fold cross‐validation and bootstrap resampling assessed model performance and threshold stability. US‐based localization was also compared with surgical findings. Results: Sixty‐nine boys were included; surgery identified 51 NVT and 18 VT. Optimal cutoffs were A = −2.60, B = +0.45, and C = +0.60. The model achieved an AUC of 96.1%, with 100% sensitivity, 92.2% specificity, 81.8% positive predictive value, and 100% negative predictive value. Internal validation showed median AUCs of 90.0% and 89.4%, with stable thresholds. Localization accuracy was 66.6%. Conclusion: A rulebased US model may predict monorchidism in unilateral NPT with a very low risk of misclassifying VT as NVT, despite its limited ability to determine testicular location.
- 20 March 2024
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 39 (5) , 1131-1140
Systematic molecular analyses for 115 karyotypically normal men with isolated non-obstructive azoospermia
Do copy-number variations (CNVs) in the azoospermia factor (AZF) regions and monogenic mutations play a major role in the development of isolated (non-syndromic) non-obstructive azoospermia (NOA) in Japanese men with a normal 46, XY karyotype? Deleterious CNVs in the AZF regions and damaging sequence variants in eight genes likely constitute at least 8% and approximately 8% of the genetic causes, respectively, while variants in other genes play only a minor role. Sex chromosomal abnormalities, AZF-linked microdeletions, and monogenic mutations have been implicated in isolated NOA. More than 160 genes have been reported as causative/susceptibility/candidate genes for NOA. Systematic molecular analyses were conducted for 115 patients with isolated NOA and a normal 46, XY karyotype, who visited our hospital between 2017 and 2021. We studied 115 unrelated Japanese patients. AZF-linked CNVs were examined using sequence-tagged PCR and multiplex ligation-dependent probe amplification, and nucleotide variants were screened using whole exome sequencing (WES). An optimized sequence kernel association test (SKAT-O), a gene-based association study using WES data, was performed to identify novel disease-associated genes in the genome. The results were compared to those of previous studies and our in-house control data. Thirteen types of AZF-linked CNVs, including the hitherto unreported gr/gr triplication and partial AZFb deletion, were identified in 63 (54.8%) cases. When the gr/gr deletion, a common polymorphism in Japan, was excluded from data analyses, the total frequency of CNVs was 23/75 (30.7%). This frequency is higher than that of the reference data in Japan and China (11.1% and 14.7%, respectively). Known NOA-causative AZF-linked CNVs were found in nine (7.8%) cases. Rare damaging variants in known causative genes (DMRT1, PLK4, SYCP2, TEX11, and USP26) and hemizygous/multiple-heterozygous damaging variants in known spermatogenesis-associated genes (TAF7L, DNAH2, and DNAH17) were identified in nine cases (7.8% in total). Some patients carried rare damaging variants in multiple genes. SKAT-O detected no genes whose rare damaging variants were significantly accumulated in the patient group. The number of participants was relatively small, and the clinical information of each patient was fragmentary. Moreover, the pathogenicity of identified variants was assessed only by in silico analyses. This study showed that various AZF-linked CNVs are present in more than half of Japanese NOA patients. These results broadened the structural variations of AZF-linked CNVs, which should be considered for the molecular diagnosis of spermatogenic failure. Furthermore, the results of this study highlight the etiological heterogeneity and possible oligogenicity of isolated NOA. This study was supported by Grants from the Japan Society for the Promotion of Science (21K19283 and 21H0246), the Japan Agency for Medical Research and Development (22ek0109464h0003), the National Center for Child Health and Development, the Canon Foundation, the Japan Endocrine Society, and the Takeda Science Foundation. The results of this study were based on samples and patient data obtained from the International Center for Reproductive Medicine, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan. The authors have no conflicts of interest to disclose. N/A.
- 20 March 2024
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 39 (5) , 1131-1140
Systematic molecular analyses for 115 karyotypically normal men with isolated non-obstructive azoospermia
Do copy-number variations (CNVs) in the azoospermia factor (AZF) regions and monogenic mutations play a major role in the development of isolated (non-syndromic) non-obstructive azoospermia (NOA) in Japanese men with a normal 46, XY karyotype? Deleterious CNVs in the AZF regions and damaging sequence variants in eight genes likely constitute at least 8% and approximately 8% of the genetic causes, respectively, while variants in other genes play only a minor role. Sex chromosomal abnormalities, AZF-linked microdeletions, and monogenic mutations have been implicated in isolated NOA. More than 160 genes have been reported as causative/susceptibility/candidate genes for NOA. Systematic molecular analyses were conducted for 115 patients with isolated NOA and a normal 46, XY karyotype, who visited our hospital between 2017 and 2021. We studied 115 unrelated Japanese patients. AZF-linked CNVs were examined using sequence-tagged PCR and multiplex ligation-dependent probe amplification, and nucleotide variants were screened using whole exome sequencing (WES). An optimized sequence kernel association test (SKAT-O), a gene-based association study using WES data, was performed to identify novel disease-associated genes in the genome. The results were compared to those of previous studies and our in-house control data. Thirteen types of AZF-linked CNVs, including the hitherto unreported gr/gr triplication and partial AZFb deletion, were identified in 63 (54.8%) cases. When the gr/gr deletion, a common polymorphism in Japan, was excluded from data analyses, the total frequency of CNVs was 23/75 (30.7%). This frequency is higher than that of the reference data in Japan and China (11.1% and 14.7%, respectively). Known NOA-causative AZF-linked CNVs were found in nine (7.8%) cases. Rare damaging variants in known causative genes (DMRT1, PLK4, SYCP2, TEX11, and USP26) and hemizygous/multiple-heterozygous damaging variants in known spermatogenesis-associated genes (TAF7L, DNAH2, and DNAH17) were identified in nine cases (7.8% in total). Some patients carried rare damaging variants in multiple genes. SKAT-O detected no genes whose rare damaging variants were significantly accumulated in the patient group. The number of participants was relatively small, and the clinical information of each patient was fragmentary. Moreover, the pathogenicity of identified variants was assessed only by in silico analyses. This study showed that various AZF-linked CNVs are present in more than half of Japanese NOA patients. These results broadened the structural variations of AZF-linked CNVs, which should be considered for the molecular diagnosis of spermatogenic failure. Furthermore, the results of this study highlight the etiological heterogeneity and possible oligogenicity of isolated NOA. This study was supported by Grants from the Japan Society for the Promotion of Science (21K19283 and 21H0246), the Japan Agency for Medical Research and Development (22ek0109464h0003), the National Center for Child Health and Development, the Canon Foundation, the Japan Endocrine Society, and the Takeda Science Foundation. The results of this study were based on samples and patient data obtained from the International Center for Reproductive Medicine, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan. The authors have no conflicts of interest to disclose. N/A.
- Open Access
- 1 January 2024
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 23 (1) , e12608
Compound heterozygous KCTD19 variants in a man with isolated nonobstructive azoospermia
Case: A 40‐year‐old Japanese man with nonobstructive azoospermia (NOA) was found to carry rare variants in KCTD19, a newly identified causative gene for spermatogenic failure. This patient was identified through mutation screening of KCTD19 in 97 men with etiology‐unknown isolated NOA.Outcome: The patient had two heterozygous variants in KCTD19 that affect consensus sequences of splice‐donor sites [c.300+2T>A and c.2667C>T (p.E889E)]. Both variants were predicted to cause exon skipping. Long‐read sequencing confirmed the compound heterozygosity of the variants. The patient exhibited small testes and a mildly elevated level of follicle‐stimulating hormone but no other phenotypic abnormalities. Testicular histology showed borderline findings between spermatocyte maturation arrest and severe hypospermatogenesis.Conclusion: These results provide evidence that biallelic loss‐of‐function variants of KCTD19 represent rare causes of isolated NOA.
- 1 January 2024
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 23 (1) , e12608
Open AccessCompound heterozygous KCTD19 variants in a man with isolated nonobstructive azoospermia
Case: A 40‐year‐old Japanese man with nonobstructive azoospermia (NOA) was found to carry rare variants in KCTD19, a newly identified causative gene for spermatogenic failure. This patient was identified through mutation screening of KCTD19 in 97 men with etiology‐unknown isolated NOA.Outcome: The patient had two heterozygous variants in KCTD19 that affect consensus sequences of splice‐donor sites [c.300+2T>A and c.2667C>T (p.E889E)]. Both variants were predicted to cause exon skipping. Long‐read sequencing confirmed the compound heterozygosity of the variants. The patient exhibited small testes and a mildly elevated level of follicle‐stimulating hormone but no other phenotypic abnormalities. Testicular histology showed borderline findings between spermatocyte maturation arrest and severe hypospermatogenesis.Conclusion: These results provide evidence that biallelic loss‐of‐function variants of KCTD19 represent rare causes of isolated NOA.